← Leaderboards
Jianhua Yang
Baylor College Of Medicine
$4,705,917
Attributed
$4,705,917
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $572.5K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,705,917 · 5
By mechanism
R01$3,586,048 · 2
R21$1,119,869 · 3
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Michael D. Schneider$11,396,412
- Jeffrey Rosen$27,294,929
- James Smith$502,707
- Nikolai A Timchenko$12,558,568
- Peter E. Zage$1,722,994
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMouse ModelMalignant NeoplasmsTumor GrowthNeuroblastomaSolid NeoplasmNeuroblastoma CellChildResearch ProposalsCell LineMemberMalignant - DescriptorOverexpressionProteinsFamilyGrowthXenograft ProcedurePlayIn VivoChemotherapeutic AgentMycn GeneSignal TransductionNew Therapeutic TargetDefect
Grant awards (16)
CAMKV Kinase Signaling in Neuroblastoma$418,663
R01 · FY2024 · NS · contact PI
CAMKV Kinase Signaling in Neuroblastoma$437,251
R01 · FY2023 · NS · contact PI
CAMKV Kinase Signaling in Neuroblastoma$446,784
R01 · FY2022 · NS · contact PI
CAMKV Kinase Signaling in Neuroblastoma$1
R01 · FY2022 · NS · contact PI
CAMKV Kinase Signaling in Neuroblastoma$453,406
R01 · FY2021 · NS · contact PI
CAMKV Kinase Signaling in Neuroblastoma$475,972
R01 · FY2020 · NS · contact PI
TMEM108 IS A NOVEL TARGET IN NEUROBLASTOMA$237,750
R21 · FY2017 · NS · contact PI
TMEM108 IS A NOVEL TARGET IN NEUROBLASTOMA$198,125
R21 · FY2016 · NS · contact PI
DUSP26: A Novel Therapeutic Target in Neuroblastoma$338,921
R01 · FY2014 · NS · contact PI
Targeting TAK1 in Neuroblastoma$233,590
R21 · FY2014 · NS · contact PI
DUSP26: A Novel Therapeutic Target in Neuroblastoma$330,362
R01 · FY2013 · NS · contact PI
Targeting TAK1 in Neuroblastoma$196,625
R21 · FY2013 · NS · contact PI
DUSP26: A Novel Therapeutic Target in Neuroblastoma$342,344
R01 · FY2012 · NS · contact PI
DUSP26: A Novel Therapeutic Target in Neuroblastoma$342,344
R01 · FY2011 · NS · contact PI
Analysis of a Novel Secreted Protein in Neuroblastoma$125,381
R21 · FY2006 · CA · contact PI
Analysis of a Novel Secreted Protein in Neuroblastoma$128,398
R21 · FY2005 · CA